vTv Therapeutics (VTVT) Profit After Tax (2014 - 2026)

vTv Therapeutics (VTVT) has 13 years of Profit After Tax data on file, last reported at $24.1 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 488.19% year-over-year to $24.1 million; the trailing twelve-month figure through Mar 2026 stood at -$729000.0 (up 97.1% YoY), and the FY2025 full-year result was -$27.0 million, down 18.8% from the prior year.
• Profit After Tax climbed to $24.1 million in Q1 2026, from -$7.1 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $24.1 million in Q1 2026 to a low of -$10.3 million in Q3 2025.
• A 5-year average of -$4.1 million and a median of -$5.6 million in 2023 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax tumbled 717.8% in 2024 and jumped 488.19% in 2026, its largest moves.
• Tracing VTVT's Profit After Tax over 5 years: stood at -$4.7 million in 2022, then jumped by 126.87% to $1.3 million in 2023, then plunged by 717.8% to -$7.9 million in 2024, then climbed by 9.38% to -$7.1 million in 2025, then soared by 438.11% to $24.1 million in 2026.
• Business Quant data shows VTVT's Profit After Tax at $24.1 million in Q1 2026, -$7.1 million in Q4 2025, and -$10.3 million in Q3 2025.